NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 845 filers reported holding NOVARTIS A G in Q2 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $275,000 | +14.1% | 3,330 | 0.0% | 0.01% | +28.6% |
| Q1 2016 | $241,000 | -96.9% | 3,330 | -96.3% | 0.01% | -97.0% |
| Q4 2015 | $7,675,000 | -21.9% | 89,202 | -16.6% | 0.23% | -24.4% |
| Q3 2015 | $9,827,000 | -47.3% | 106,914 | -43.7% | 0.31% | -39.4% |
| Q2 2015 | $18,664,000 | +9.2% | 189,788 | +9.5% | 0.51% | +6.5% |
| Q1 2015 | $17,098,000 | +8.3% | 173,395 | +1.7% | 0.48% | +8.4% |
| Q4 2014 | $15,794,000 | -2.0% | 170,449 | -0.4% | 0.44% | -4.8% |
| Q3 2014 | $16,115,000 | +5.7% | 171,196 | +1.7% | 0.46% | +6.7% |
| Q2 2014 | $15,242,000 | -4.0% | 168,365 | -9.8% | 0.43% | -5.7% |
| Q1 2014 | $15,869,000 | -58.1% | 186,650 | -60.4% | 0.46% | -58.2% |
| Q4 2013 | $37,864,000 | -1.3% | 471,074 | -5.8% | 1.10% | -6.6% |
| Q3 2013 | $38,367,000 | +2.6% | 500,159 | -5.4% | 1.18% | -3.8% |
| Q2 2013 | $37,400,000 | – | 528,918 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |